These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4114202)

  • 1. [Blood-brain barrier from the standpoint of clinical medicine--blood-brain barrier and chemotherapy of brain tumor].
    Takeuchi K
    Nihon Ishikai Zasshi; 1972 May; 67(9):1225-32. PubMed ID: 4114202
    [No Abstract]   [Full Text] [Related]  

  • 2. A clinical trial of intravenous bleomycin in the treatment of brain tumors.
    Takeuchi K
    Int J Clin Pharmacol Biopharm; 1975 Dec; 12(4):419-26. PubMed ID: 54345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of brain tumors; effect of bleomycin].
    Takeuchi K; Atsuji M; Masui T; Sueyoshi S; Hara M
    No To Shinkei; 1972 Apr; 24(4):437-44. PubMed ID: 4112558
    [No Abstract]   [Full Text] [Related]  

  • 4. Bleomycin treatment of brain tumors: an evaluation.
    Linnert M; Gehl J
    Anticancer Drugs; 2009 Mar; 20(3):157-64. PubMed ID: 19396014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma. Report of three cases.
    Lafay-Cousin L; Bartels U; Raybaud C; Kulkarni AV; Guger S; Huang A; Bouffet E
    J Neurosurg; 2007 Oct; 107(4 Suppl):318-23. PubMed ID: 17941498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Penetration of 99mTcO4- into cerebrospinal fluid from blood on brain scintigraphy (author's transl)].
    Takeyama E; Ookubo T; Baba M; Beppu T; Kitamura K
    No Shinkei Geka; 1975 May; 3(5):389-97. PubMed ID: 1239680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormonal (vasopressin-corticoid) treatment of 16 cases of inoperable cerebral tumors with little or no malignant potential].
    Bernard-Weil E; Metzger J; Pertuiset B
    Sem Hop; 1973 May; 49(23):1687-97. PubMed ID: 4356221
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intracystic therapy of bleomycin for craniopharyngioma--effect of bleomycin for cultured craniopharyngioma cells and intracystic concentration of bleomycin (author's transl)].
    Kubo O; Takakura K; Miki Y; Okino T; Kitamura K
    No Shinkei Geka; 1974 Oct; 2(10):683-8. PubMed ID: 4140477
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serotonin-C 14 and the hematoencephalic barrier. Research on human biopsy material].
    Faggioli L
    Riv Sper Freniatr Med Leg Alien Ment; 1966 Dec; 90(6):1563-7. PubMed ID: 5999619
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental brain edema: application of its theory to clinical therapy].
    Hatanaka H
    Nihon Ishikai Zasshi; 1972 May; 67(9):1218-25. PubMed ID: 5064686
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic chemotherapy for a primary germ cell tumor of the brain: a pharmacokinetic study.
    Ginsberg S; Kirshner J; Reich S; Panasci L; Finkelstein T; Fandrich S; Fitzpatrick A; Shechtman L; Comis R
    Cancer Treat Rep; 1981; 65(5-6):477-83. PubMed ID: 6165472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy.
    Dahlborg SA; Henner WD; Crossen JR; Tableman CM; Petrillo A; Braziel R; Neuwelt EA
    Cancer J Sci Am; 1996; 2(3):166-74. PubMed ID: 9166517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Problems specific to chemotherapy of intracerebral tumors].
    Hirsch JF
    Neurochirurgie; 1974; 20(3):233-46. PubMed ID: 4219038
    [No Abstract]   [Full Text] [Related]  

  • 14. Pituitary function after endonasal surgery for nonadenomatous parasellar tumors: Rathke's cleft cysts, craniopharyngiomas, and meningiomas.
    Dusick JR; Fatemi N; Mattozo C; McArthur D; Cohan P; Wang C; Swerdloff RS; Kelly DF
    Surg Neurol; 2008 Nov; 70(5):482-90; discussion 490-1. PubMed ID: 18482750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.
    Neuwelt EA; Rapoport SI
    Fed Proc; 1984 Feb; 43(2):214-9. PubMed ID: 6692941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A device for prolonged releasing of anticancer drug--bleomycin: Second report].
    Katakura R; Mori T; Suzuki J
    No Shinkei Geka; 1982 Sep; 10(9):941-4. PubMed ID: 6184638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of fluid in craniopharyngioma-related cysts in children: proteins, lactate and pH.
    Arefyeva IA; Semenova JB; Zubairaev MS; Kondrasheva EA; Moshkin AV
    Acta Neurochir (Wien); 2002 Jun; 144(6):551-4; discussion 554. PubMed ID: 12111487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blood-brain barrier disruption controversy: does it hold water?
    Ruffer JE; Glatstein E
    Cancer J Sci Am; 1998; 4(2):84-5. PubMed ID: 9532409
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy in brain tumors].
    van den Bent MJ; Schellens JH; Sillevis Smitt PA; Vecht CJ
    Ned Tijdschr Geneeskd; 1996 Mar; 140(13):702-6. PubMed ID: 8668248
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
    Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M
    Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.